Zelboraf tablets (Vemurafenib)

What is Zelboraf tablets (Vemurafenib)
Zelboraf tablets is an oral, small molecule, kinase inhibitor for the treatment of Metastatic Melanoma.

Zelboraf

Drug Manufacturer / Marketeer :

Roche, Basel, Switzerland


Available as:

240MG TABLETS.

Indications:
Zelboraf tablets (Vemurafenib) is indicated for the treatment of unresectable or Metastatic Melanoma with detection of a BRAF mutation.

Treatment:
For treatment related information, please consult your treating Physician.

How supplied:
Zelboraf (Vemurafenib) is available in 240 mg tablets, and is presented in a bottle of 120 tablets.

Storage and handling:
Store at 20°- 25° C, excursions permitted to 15° to 30° C.

How do we source the Drug?
SMIQ Pharma-India will assist in sourcing the drug through its efficient network,  across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is essential.

Company that Manufactures/ Markets:
Roche, Basel, Switzerland

Assistance Cell in India:
For ONCOLOGY DRUG: Zelboraf tablets (Vemurafenib) 240MG price.

Contact us @ +91 7678048225 or by email  info@smiqpharma.com.